Propanc Biopharma, Inc.
PPCB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001517681
No open-market purchases or sales by Propanc Biopharma, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $71.5K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Propanc Biopharma, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 3 | 5 | +2 |
| Shares | 112.1K | 128.9K | +16.8K (+15.0%) |
| Value | $190.7K | $69.5K | −$121.3K (−63.6%) |
New holders (3)
Institutions that held Propanc Biopharma, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 25,483 | $13.7K | 0.00% |
| XTX Topco Ltd | 22,126 | $11.9K | 0.00% |
| Two Sigma Investments, LP | 16,257 | $8.72K | 0.00% |
Sold out (1)
Institutions that held Propanc Biopharma, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Virtu Financial LLC | 41,677 | $71.0K |